✦ LIBER ✦

NEOADJUVANT METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN FOR HISTOLOGICALLY PROVEN LYMPH NODE POSITIVE BLADDER CANCER

✍ Scribed by NIEUWENHUIJZEN, J; BEX, A; MEINHARDT, W; KERST, J; SCHORNAGEL, J; VANTINTEREN, H; HORENBLAS, S

Book ID: 123223102
Publisher: Lippincott Williams and Wilkins
Year: 2005
Tongue: English
Weight: 260 KB
Volume: 174
Category: Article
ISSN: 0022-5347
DOI: 10.1097/01.ju.0000162018.40891.ba

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Methotrexate, Vinblastine, Doxorubicin a

Methotrexate, Vinblastine, Doxorubicin and Cisplatin Chemotherapy and Cystectomy for Unresectable Bladder Cancer

✍ DONAT, S; HERR, H; BAJORIN, D; FAIR, W; SOGANI, P; RUSSO, P; SHEINFELD, J; SCHER 📂 Article 📅 1996 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 413 KB

Neoadjuvant methotrexate, vinblastine, d

Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin for locally advanced transitional cell carcinoma of the bladder

✍ Ralph J. Miller Jr.; Robert R. Bahnson; Barbara Banner; Marc S. Ernstoff; Walter 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 2 views

Neoadjuvant m-vac (methotrexate, vinblas

Neoadjuvant m-vac (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder

✍ Cora N. Sternberg; Maria G. Arena; Federico Calabresi; Piero De Carli; Andrea Pl 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 747 KB

Predicting Response to Methotrexate, Vin

Predicting Response to Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Neoadjuvant Chemotherapy for Bladder Cancers Through Genome-Wide Gene Expression Profiling

✍ Takata, R.; Katagiri, T.; Kanehira, M.; Tsunoda, T.; Shuin, T.; Miki, T.; Namiki 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 34 KB

Neoadjuvant cisplatin,methotrexate,and v

Neoadjuvant cisplatin,methotrexate,and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial

📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 72 KB

Multimodal therapy including neoadjuvant

Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) for stage IIB to IV cervical cancer

✍ Sean C. Dowdy; Cecelia H. Boardman; Timothy O. Wilson; Karl C. Podratz; Lynn C. 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 102 KB